AstraGin®, Developed by NuLiv Science, Demonstrates Improvements in Gut Health in Human Clinical Trial

BREA, Calif., April 3, 2023 /PRNewswire/ — A groundbreaking human clinical trial published in the Journal of Biochemistry and Biotechnology reveals AstraGin®’s significant impact on various factors related to gut health in patients with Ulcerative Colitis (UC). AstraGin® human study…